Pfizer’s Mixed Readout Places Doubt On Oral GLP-1 For Obesity

 
• By Joseph Haas
  
Pfizer sign
Pfizer puts hopes for oral GLP-1 agonist on daily formulation work
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D